Comparison of the exposure of glycyrrhizin and its metabolites and the pseudoaldosteronism after intravenous administration of alpha- and beta-glycyrrhizin in rat

Drug Research

Volumn 63, Issue 12, 2013, Pages 620-624

  Xu, R ^a   Xiao, Q ^a   Cao, Y ^a   Yang, J ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

3 monoglucuronyl glycyrrhetinic acid; glycyrrhetinic acid; isomer; pseudoaldosteronism; systemic exposure

Indexed keywords

ALPHA GLYCYRRHIZIC ACID; BIOLOGICAL MARKER; DICLOFENAC; GLYCYRRHIZIC ACID; GLYCYRRHIZIC ACID DERIVATIVE; LOSARTAN; MAGNESIUM ISOGLYCYRRHIZINATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; HYDROCORTISONE URINE LEVEL; HYPERALDOSTERONISM; ISOMER; NONHUMAN; PSEUDOALDOSTERONISM; RAT; SINGLE DRUG DOSE; URINALYSIS;

EID: 84890995398     PISSN: 21949379     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0033-1349837     Document Type: Article

References (15)

1. Asl M. N., Hosseinzadeh H. Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds. Phytother Res: 2008; 22 709 724
2. Koga K., Ohmachi K., Kawashima S. et al. Determination of 18alpha-glycyrrhizin and 18beta-glycyrrhizin in dog plasma by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl: 2000; 738 165 168
3. Sun L., Shen J., Pang X. et al. Phase I safety and pharmacokinetic study of magnesium isoglycyrrhizinate after single and multiple intravenous doses in chinese healthy volunteers. J Clin Pharmacol: 2007; 47 767 773
4. Qu Y., Chen W. H., Zong L. et al. 18alpha-Glycyrrhizin induces apoptosis and suppresses activation of rat hepatic stellate cells. Med Sci Monit: 2012; 18 BR24 BR32
5. Mao Yimin Z. M., Chen Y., Chen C. et al. Magnesium isoglycyrrhizinate in the treatment of chronic liver diseases: A randomized, double-blind, multi-doses, active drug controlled, multi-center study. Chinese Journal of Hepatology: 2009; 17 847 851
6. Farese R. V. Jr, Biglieri E. G., Shackleton C. H. et al. Licorice-induced hypermineralocorticoidism. N Engl J Med: 1991; 325 1223 1227
7. Serra A., Uehlinger D. E., Ferrari P. et al. Glycyrrhetinic acid decreases plasma potassium concentrations in patients with anuria. J Am Soc Nephrol: 2002; 13 191 196
8. Kato H., Kanaoka M., Yano S. et al. 3-Monoglucuronyl-glycyrrhetinic acid is a major metabolite that causes licorice-induced pseudoaldosteronism. J Clin Endocrinol Metab: 1995; 80 1929 1933
9. Ohtake N., Kido A., Kubota K. et al. A possible involvement of 3-monoglucuronyl-glycyrrhetinic acid, a metabolite of glycyrrhizin (GL), in GL-induced pseudoaldosteronism. Life Sci: 2007; 80 1545 1552
10. Makino T., Okajima K., Uebayashi R. et al. 3-Monoglucuronyl- glycyrrhretinic acid is a substrate of organic anion transporters expressed in tubular epithelial cells and plays important roles in licorice-induced pseudoaldosteronism by inhibiting 11beta-hydroxysteroid dehydrogenase 2. J Pharmacol Exp Ther: 2012; 342 297 304
11. Pippal J. B., Fuller P. J. Structure-function relationships in the mineralocorticoid receptor. J Mol Endocrinol: 2008; 41 405 413
12. Palermo M., Shackleton C. H., Mantero F. et al. Urinary free cortisone and the assessment of 11 beta-hydroxysteroid dehydrogenase activity in man. Clin Endocrinol (Oxf): 1996; 45 605 611
13. Best R., Walker B. R. Additional value of measurement of urinary cortisone and unconjugated cortisol metabolites in assessing the activity of 11 beta-hydroxysteroid dehydrogenase in vivo. Clin Endocrinol (Oxf): 1997; 47 231 236
14. Cuzzola A., Petri A., Mazzini F. et al. Application of hyphenated mass spectrometry techniques for the analysis of urinary free glucocorticoids. Rapid Commun Mass Spectrom: 2009; 23 2975 2982
15. Omar H. R., Komarova I., El-Ghonemi M. et al. Licorice abuse: time to send a warning message. Ther Adv Endocrinol Metab: 2012; 3 125 138